Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2000 | 06-2000 | 03-2000 | 12-1999 | 09-1999 | |
| Sales | 9,594 | 20,365 | 15,500 | 8,058 | 10,573 |
| Gross Profit | 9,594 | 20,365 | 15,500 | 8,070 | 10,570 |
| Operating Expenses | 12,433 | 13,086 | 13,527 | 13,870 | 10,380 |
| Operating Income | -2,839 | 7,279 | 1,973 | -5,812 | 193 |
| Interest Expense | 2,255 | 2,257 | 1,203 | 150 | 0 |
| Other Income | 0 | 0 | 0 | 12 | -13 |
| Pre-tax Income | -5,094 | 5,022 | 770 | -5,950 | 180 |
| Net Income Continuous | -5,094 | 5,022 | 770 | -5,948 | 181 |
| Net Income | $-5,094 | $5,022 | $770 | $-5,948 | $181 |
| EPS Basic Total Ops | -0.06 | 0.07 | 0.01 | -0.08 | 0.00 |
| EPS Basic Continuous Ops | -0.06 | 0.06 | 0.01 | -0.08 | 0.00 |
| EPS Diluted Total Ops | -0.06 | 0.06 | 0.01 | -0.08 | 0.00 |
| EPS Diluted Continuous Ops | -0.06 | 0.06 | 0.01 | -0.08 | 0.00 |
| EBITDA(a) | $-1,877 | $8,362 | $2,824 | $-4,942 | $1,093 |